Long-term storage of trial master data. Physical or Electronic?
Recent changes to the European Medicines Agency’s (EMA) guidance requires that Trial Master File (TMF) data is kept in an accessible and readable format for a minimum period of 25 years. As such, all pharmaceutical companies have a regulatory requirement for the long-term storage of data. Whilst there remains the argument that paper records storage [...]